Wen Chen Email & Phone Number | • Highly motivated pharma professional with medical school, pharmacy school trainings, and doctorial degree in pharmaceutical Science. • Successfully developed and commercialized multiple pharmaceutical products. Recent NDA approval (July, 2019) : Xpovio (selinexor). • . Executed and managed GMP scale-up productions for both clinical phases and commercial scales. • Experienced in pre-formulation and optimizations through statistical/experimental designs and factorial studies. • Worked for CMO/CRO and served many pharmaceutical partners and clients for their product development needs. Out-sourced multiple products to different external organizations in various stages. • Member of cross-functional team, or the multi-disciplinary business team and science team, and due diligence team (product out-license and in-license). • Authorship of CMC sections for IND/IMPD, NDA/MAA, ANDA, 510K filings, etc.

Wen Chen

• Highly motivated pharma professional with medical school, pharmacy school trainings, and doctorial...
Woburn, Massachusetts, United States

*50 free lookup(s) per month.

Wen Chen’s Phone Numbers

Get WEN’s Phone Number (For Free)

Social Media

Wen Chen’s Location Woburn, Massachusetts, United States

Wen Chen’s Current Industry Eccogene 诚益生物

Find accurate emails & phone numbers for over 700M professionals.

Head of CMC

2022-01-01 00:00:00 - Present

Senior Director of Pharmaceutical Sciences, Formulation Development

2013-01-01 00:00:00 - 2022-01-01 00:00:00

Director, Formulation Technology

2011-01-01 00:00:00 - 2013-01-01 00:00:00

Director Pharmaceutical technology

2007-01-01 00:00:00 - 2010-01-01 00:00:00

Pharmaceutical Services

2004-01-01 00:00:00 - 2007-01-01 00:00:00

Formulation/Manufacturing

2000-01-01 00:00:00 - 2004-01-01 00:00:00

Formulation

1999-01-01 00:00:00 - 2000-01-01 00:00:00

formulation

1996-01-01 00:00:00 - 1998-01-01 00:00:00

No Skills Available

No Languages Available

Wen Chen is a • Highly motivated pharma professional with medical school, pharmacy school trainings, and doctorial degree in pharmaceutical Science. • Successfully developed and commercialized multiple pharmaceutical products. Recent NDA approval (July, 2019) : Xpovio (selinexor). • . Executed and managed GMP scale-up productions for both clinical phases and commercial scales. • Experienced in pre-formulation and optimizations through statistical/experimental designs and factorial studies. • Worked for CMO/CRO and served many pharmaceutical partners and clients for their product development needs. Out-sourced multiple products to different external organizations in various stages. • Member of cross-functional team, or the multi-disciplinary business team and science team, and due diligence team (product out-license and in-license). • Authorship of CMC sections for IND/IMPD, NDA/MAA, ANDA, 510K filings, etc.

Wen Chen has prior
experience in the following industries:
Karyopharm Therapeutics | Acebright | Idenix Pharmaceuticals | Nucryst Pharmaceuticals | Tedor Pharmaceuticals | Copley Pharmaceuticas | Eos Pharmaceuticals

Wen Chen has the following professional experience:
Eccogene 诚益生物 | Karyopharm Therapeutics | Acebright | Idenix Pharmaceuticals | Nucryst Pharmaceuticals | Tedor Pharmaceuticals | Copley Pharmaceuticas | Eos Pharmaceuticals